Odf2 activators are a class of compounds that influence cellular signaling pathways and processes that can enhance the functional activity of Odf2. Forskolin, by raising intracellular cAMP levels, can activate protein kinase A (PKA), which could phosphorylate Odf2 or associated proteins, thus enhancing its activity. Similarly, IBMX, by inhibiting phosphodiesterases, leads to the accumulation of cAMP and cGMP, which can activate PKA and PKG pathways that may phosphorylate and activate proteins linked with Odf2. PMA's activation of protein kinase C (PKC) and the resulting changes in the cytoskeleton could affect Odf2's function or stability, while the calcium ionophore A23187 increases intracellular calcium, activating calcium-dependent kinases that might modify Odf2.
Thapsigargin, by increasing cytosolic calcium concentration, can activate calcium signaling pathways that influence Odf2 function. Lithium chloride's inhibition of GSK-3 can stabilize and activate proteins within pathways that affect Odf2. EGFtriggers the MAPK/ERK pathway, which can phosphorylate a range of proteins, potentially including those associated with Odf2, leading to its activation. Insulin signaling through its receptor initiates a cascade that activates the PI3K/Akt pathway, which may affect various cellular processes and proteins linked to Odf2. Cholera toxin's continuous activation of adenylate cyclase due to permanent Gs alpha protein activation can enhance PKA activity, potentially resulting in the indirect activation of Odf2. Okadaic acid's inhibition of protein phosphatases PP1 and PP2A leads to higher phosphorylation levels of cellular proteins, which could include those related to Odf2. Ouabain alters ion gradients by inhibiting the Na+/K+ ATPase pump, which can influence signaling pathways and proteins interacting with Odf2. Lastly, NAD+, as a crucial coenzyme in redox reactions, can affect sirtuin activity, potentially leading to the deacetylation and modulation of proteins that are associated with Odf2, thereby enhancing its functional activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels in cells. Elevated cAMP enhances PKA activity, which can phosphorylate various proteins, potentially including structural proteins like Odf2, to affect their function. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases which prevents the breakdown of cAMP and cGMP, leading to their accumulation. This can enhance PKA and PKG pathways, which could phosphorylate and activate proteins associated with Odf2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a variety of proteins. PKC activation can lead to changes in the cytoskeleton and associated proteins, potentially affecting Odf2's activity or stability. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium levels, which can activate calmodulin and calcium-dependent kinases that might phosphorylate or otherwise modify the activity of proteins like Odf2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium concentration which can activate calcium signaling pathways potentially influencing Odf2 function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium inhibits glycogen synthase kinase 3 (GSK-3), leading to the stabilization and activation of various proteins and signaling pathways that can have downstream effects on proteins like Odf2. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin binds to its receptor, initiating a signaling cascade that activates PI3K/Akt pathway, which can influence various proteins and cellular processes, potentially affecting Odf2. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins within the cell, which could include those related to Odf2 activity. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain is an inhibitor of the Na+/K+ ATPase pump, altering ion gradients and potentially influencing signaling pathways and proteins interacting with Odf2. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ is a coenzyme involved in redox reactions. It can influence sirtuin activity, which can deacetylate and affect the function of various proteins, potentially including those associated with Odf2. | ||||||